💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

January saw record US leveraged loan issuance - JPMorgan

Published 02/01/2024, 10:51 AM
Updated 02/01/2024, 10:57 AM
© Reuters. FILE PHOTO: U.S. dollar banknotes are seen in this illustration taken March 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

By Matt Tracy

(Reuters) - This January broke a record in gross U.S. institutional leveraged loan issuance, as companies took advantage of a decline in borrowing costs, according to a Thursday report by JPMorgan.

The first month of the year recorded $140.1 billion in gross institutional loan issuance, according to JPMorgan. The last-highest net institutional loan issuance took place in November 2021 at $75 billion.

Last month also saw the heaviest refinancing volume on record at $51.4 billion, and the second-heaviest repricing volume at $78.7 billion, the Thursday report noted.

The record-breaking month came as corporate borrowers capitalized on fourth-quarter declines in borrowing costs to refinance existing debt and issue new debt.

Leveraged loan yields fell 66 basis points (bps) in December, while spreads slid 22 bps, JPMorgan noted. Yields declined a further 13 bps to finish trading on Wednesday at 8.61%, while spreads inched up one bp to 496 bps.

Wednesday's fall in yields follows the U.S. Federal Reserve's January meeting, where the Fed held its key interest rate steady but reiterated it could begin cutting rates later this year.

The high-yield primary market also saw its most active month in January since November 2021, with January volume hitting $31 billion.

© Reuters. FILE PHOTO: U.S. dollar banknotes are seen in this illustration taken March 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

Bond yields rose four bps to 7.92% on Wednesday, while spreads climbed 17 bps to 390 bps.

Four high-yield bond deals priced on Wednesday. These include $1 billion in five-year non-call two notes on behalf of molding systems supplier Husky Injection and $725 million in senior secured five-year non-call two notes for chemical producer INEOS.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.